A 30-year veteran of the Food and Drug Administration said at a congressional hearing this week he resigned in part because top brass sidelined his office to rush the full approval of Pfizer’s COVID-19 vaccine in August 2021, apparently to legally enable a vaccine mandate, then a booster under emergency use authorization over the objections of the agency’s outside advisers.
But former Office of Vaccines Research and Review Deputy Director Philip Krause perhaps saved his biggest embarrassment to the FDA for the end of Wednesday’s hearing on alleged Biden administration political interference in COVID vaccine review: He declined the booster.
Read More